Parkview Health’s October 16 agreement to acquire Ovation Healthcare provides a useful starting point for examining how equipment recovery services fit into hospital technology management. Parkview describes Ovation as a shared-services provider serving more than 500 healthcare organizations across 48 states, including independent and rural hospitals. Ovation’s published Technology Services include End User Computing, where the company says it oversees device lifecycle management, and Infrastructure Support covering servers and storage.
Those services concern healthcare IT equipment and infrastructure; they do not establish that Ovation manages or refurbishes regulated clinical medical devices. The distinction is important for IT asset disposition (ITAD) providers considering the wider healthcare sector. As discussed in the companion report, Parkview–Ovation Acquisition Expands Rural Hospital Shared Services, With Implications for IT Asset Recovery — U.S. Outlook, shared-services relationships can provide an additional route to hospital technology customers. Handling retired clinical equipment, however, introduces requirements that extend beyond conventional enterprise IT processing.
Key Findings & Outlook
- Servicing and remanufacturing carry different regulatory consequences. The FDA determines the distinction from the activities performed on a finished medical device. Work that significantly changes specified performance, safety or intended-use characteristics can constitute remanufacturing.
- Cybersecurity remains relevant throughout device servicing. The FDA identifies cybersecurity as an important consideration in medical-device servicing and expects manufacturers and healthcare organizations to address their respective responsibilities.
- Clinical reuse requires a separate equipment assessment. Passing a functional test does not establish that a used medical device has adequate software support or is suitable for a particular receiving healthcare organization.
- Intake controls should reflect the actual equipment. Data handling and possible clinical contamination require documented acceptance procedures appropriate to the device and its previous use.
- Shared-services relationships offer a potential coordination model. Common intake specifications and specialist handling arrangements could help smaller hospitals obtain appropriate recovery services, subject to each institution’s contractual authority.
Servicing and remanufacturing: where recovery work changes regulatory status
The FDA distinguishes servicing from remanufacturing according to the work performed on a finished medical device. Servicing involves repair or preventive and routine maintenance intended to return equipment to the original equipment manufacturer’s safety and performance specifications and its original intended use. Remanufacturing involves processing or modifying a finished device in ways that significantly change its performance or safety specifications, or intended use.
The classification depends on the actual activity. The FDA makes clear that an organization’s description of itself as a servicer or remanufacturer does not determine the regulatory treatment of its work. Companies performing remanufacturing are subject to applicable manufacturer obligations, including registration and listing requirements, adverse event reporting, the Quality Management System Regulation (QMSR) and relevant marketing submissions.
The QMSR became effective on February 2, 2026, amending 21 CFR Part 820 and incorporating ISO 13485:2016 into the U.S. medical-device quality management framework. Its application depends on the regulated manufacturing activity and the device concerned. Collection or transport of retired healthcare equipment does not, by itself, demonstrate that a recovery provider is performing remanufacturing.
For ITAD companies, the practical distinction begins with defining the services they intend to offer. Receiving equipment for secure custody and authorized transfer presents a different operating proposition from modifying a finished clinical device for return to patient use. Where refurbishment requires changes affecting device safety or intended use, the provider must establish the regulatory implications before undertaking the work.
A hospital selecting a recovery contractor should make the intended disposition route explicit. Equipment destined for continued clinical use needs assessment by an organization capable of determining what work is appropriate. A general ITAD provider can participate in collection and controlled transfer while assigning specialized device work to appropriately qualified organizations.
Software support and clinical resale eligibility
Cybersecurity creates another qualification for equipment entering the medical-device secondary market. The FDA states that connected medical devices can be vulnerable to security breaches affecting their safety and effectiveness. It also identifies cybersecurity as an important consideration during servicing and says manufacturers and healthcare delivery organizations share responsibility for managing these risks.
Section 524B of the Federal Food, Drug, and Cosmetic Act establishes requirements for sponsors of specified premarket submissions involving qualifying cyber devices. These include plans for monitoring postmarket vulnerabilities, processes for providing appropriate software updates and patches, and software bills of materials. The FDA’s February 2026 cybersecurity guidance addresses these provisions and supersedes the guidance issued June 27, 2025. The February revision is regulatory background here, not evidence that hospitals must replace older equipment or that retirement volumes have increased.
Historical FDA communications demonstrate that cybersecurity concerns have led to specific hardware decisions. In June 2019, the agency recommended that patients replace affected Medtronic MiniMed Paradigm insulin pumps with models providing better protection against the identified risks. In December 2021, the FDA reported that Fresenius Kabi had identified approximately 1,200 Agilia infusion pumps requiring hardware changes to address vulnerabilities. These cases document particular interventions and cannot be used to estimate the broader medical-equipment recovery market.
A clinically functional device can have limited resale prospects if the receiving organization cannot obtain the software support needed for safe operation. Refurbishers should therefore assess manufacturer support and the intended receiving environment before assigning resale value. Hardware testing remains important, but it cannot settle every question affecting continued clinical use.
For an ITAD provider, that assessment affects how incoming equipment should be categorized. Assets with an established, supportable reuse channel deserve different treatment from devices whose software status or intended clinical application remains unresolved. The outcome also influences whether the provider needs a specialist refurbishment partner before offering equipment for sale.
Data handling on clinical and connected equipment
The FDA advises healthcare delivery organizations to evaluate network security and protect hospital systems. Its cybersecurity resources also discuss vulnerabilities that can expose sensitive information or permit unauthorized changes to device settings. This makes information security a consideration when connected clinical equipment is withdrawn from service.
A hospital disposition program should examine where information is retained within each equipment category. Depending on device design, an asset might contain embedded storage or configuration settings, while related patient information could reside in an attached workstation or another system. Removing a conventional computer drive should not be assumed to resolve every information-security requirement.
Network credentials and retained configuration information also deserve attention during transfer. The originating hospital should establish which information must be protected or removed, and the receiving contractor should confirm that its procedures are suitable for the equipment being accepted. Where safe sanitization depends on proprietary tools or manufacturer instructions, a specialist assessment may be appropriate.
These requirements can affect the scope of an ITAD contract. The provider needs clarity about whether equipment will arrive already sanitized or whether it has been authorized to perform specific data-handling work. The intended outcome should be documented so that the hospital can reconcile assets leaving its control with the services actually performed.
Decontamination and equipment intake controls
Clinical equipment can present handling considerations associated with its previous patient-care use. The FDA’s reusable medical-device reprocessing guidance explains that reprocessing removes biological debris and inactivates infectious microorganisms so that devices can safely be used for another patient. It emphasizes that different reusable devices require specific procedures, with cleaning followed by disinfection or sterilization as appropriate.
That guidance concerns the safe reuse of medical devices in patient care. It is not a general electronics-recycling standard and does not prescribe a universal cleaning procedure for every retired hospital asset. The requirements for a disposition shipment need to reflect the device concerned and the conditions under which it was used.
Hospitals and recovery providers should agree on equipment acceptance conditions before collection. The originating organization should identify whether decontamination is necessary and who is responsible for completing it. A receiving ITAD facility needs enough information to determine whether the equipment is within its handling capabilities.
Documentation should be appropriate to the equipment and the agreement. Where decontamination is required, confirmation of the procedure or release condition can help the receiving organization manage its acceptance decision. Equipment requiring specialized processing should be separated from routine enterprise IT shipments until an appropriate handling route has been arranged.
The same considerations apply to downstream recyclers. Their acceptance specifications need to distinguish ordinary computers from clinical equipment requiring different procedures. A facility should avoid accepting an unfamiliar device category until it has established the handling requirements and an authorized processing destination.
Shared-services networks and equipment recovery
Parkview’s announced acquisition of Ovation illustrates the organizational setting in which these questions can arise. Ovation advertises lifecycle management for end-user equipment and infrastructure support for hospital IT operations. Its published services provide a basis for examining cooperation between hospital technology teams and outside recovery providers, while offering no evidence that Ovation itself conducts clinical-device disposition.
The Joint Commission’s equipment inventory guidance offers another relevant reference point. For organizations using its accreditation process for deemed status, the written inventory must include all medical equipment and identify high-risk devices. Alternative equipment maintenance arrangements are permitted within specified limits, while imaging and radiologic equipment are excluded from those alternatives. The FAQ was last updated December 30, 2025, with the organization describing the changes as editorial.
Shared-services networks could help participating hospitals develop consistent specifications for different categories of retired equipment. A common approach to identifying device types and assigning specialist handling responsibilities could reduce the administrative effort involved in purchasing recovery services. Each hospital would still need to determine who has authority to approve equipment transfer and which requirements apply to its assets.
Rural hospitals present a particular commercial consideration because small equipment batches can make individual collection projects expensive. Coordinated transport could improve operating efficiency where participating facilities are sufficiently close and their equipment meets compatible acceptance requirements. Geographic dispersion can also erode the savings, so collection economics need to be evaluated using actual facility locations and expected volumes.
Specialist partnerships offer another possible arrangement. An ITAD provider could handle suitable enterprise IT assets while working with medical-equipment specialists on devices intended for continued clinical use. Such an arrangement would require clearly assigned responsibilities, particularly where equipment requires technical assessment before resale.
The Parkview–Ovation agreement does not establish new clinical-equipment recovery contracts or changed disposition authority. Its relevance is that it provides a current example of healthcare services organized across a national customer network. The handling requirements described here remain applicable when a hospital elects to retire clinical equipment, regardless of which organization manages its conventional IT infrastructure.
Strategic Recommendations
ITAD providers and medical equipment recovery companies
- Define acceptance categories before quoting recovery work. Separate conventional hospital IT equipment from regulated clinical devices and identify which types the company can safely receive. Obtain enough information about the proposed assets to establish the appropriate handling route.
- Set a clear boundary around servicing and refurbishment. Examine the FDA’s distinction before offering repair or modification services intended to prepare a device for clinical reuse. Engage appropriately qualified specialists where device-specific technical or regulatory expertise is necessary.
- Evaluate software support before valuing clinical equipment. Establish the intended receiving market and relevant manufacturer support arrangements. Use supportable resale assumptions and avoid treating successful hardware testing as the sole measure of suitability.
Hospital ITAM, HTM and sustainability executives
- Coordinate asset release with healthcare technology management. Equipment inventories and maintenance histories can help identify the type and condition of a device before it is transferred. Confirm the authorized disposition route and the organization responsible for approving it.
- Specify data handling and decontamination responsibilities. Define the evidence required from contractors and the procedures that must be completed before shipment. Match the requirements to the equipment rather than applying a single generic acceptance rule.
- Consider coordinated recovery among participating facilities. Shared collection arrangements deserve evaluation where volumes and geographic concentration support them. Hospitals should preserve clear authority over asset transfer and contractual responsibilities.
Downstream electronics recyclers
- Establish clinical-equipment intake restrictions. Identify which devices the facility can process and which require specialist downstream arrangements. Do not accept equipment with unresolved handling requirements merely because it contains recyclable electronics.
- Require adequate shipment information. Obtain equipment identification and confirmation of relevant decontamination responsibilities before receiving unfamiliar clinical assets. Keep material recovery forecasts tied to actual authorized equipment releases.
Sources
- Parkview Health — Agreement to Acquire Ovation Healthcare, October 16, 2026
- Ovation Healthcare — Technology Services
- FDA — Remanufacturing and Servicing Medical Devices
- FDA — Quality Management System Regulation
- FDA — Medical Device Cybersecurity
- FDA — February 2026 Cybersecurity Guidance
- U.S. House Office of the Law Revision Counsel — 21 U.S.C. § 360n-2, Section 524B
- The Joint Commission — Medical Equipment Inventory and Maintenance Strategies
- FDA — How Are Reusable Medical Devices Reprocessed?